Where Will Gilead Sciences Be in 1 Year?
These days, when most people think of Gilead Sciences (NASDAQ: GILD), they think of remdesivir -- the company's investigational coronavirus treatment.
The drug was recently given emergency use authorization by the Food and Drug Administration for severe cases of COVID-19, the illness caused by the novel coronavirus. Earlier this month, Japan became the first country to approve the drug as a treatment for COVID-19.
Image source: Getty Images.
Source Fool.com
